There were some studies to demonstrate the prognostic significance of FOXP3+ Tregs which could lead to poor outcomes in many cancers, such as prostate cancer, lung cancer, hepatocellular carcinoma, and renal cell carcinoma.[13–17]. The gene discussed is FOXP3; the disease is cancer.